Quantitative image analysis in COVID-19 acute respiratory distress syndrome: a cohort observational study. [version 1; peer review: awaiting peer review]
暂无分享,去创建一个
J. Goldin | T. Dolinay | Brandon S. Grimes | Augustine Chung | G. Kim | Li-Sheng Hsu | D. Jun | A. Maller | D. Nelson | B. Villagas
[1] E. Hoffman,et al. Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length , 2021, Thorax.
[2] D. García-Gasulla,et al. Pulmonary Function and Radiological Features in Survivors of Critical Covid-19: A 3-Month Prospective Cohort , 2021, C4. C004 BEST OF IMAGING 2021: FROM PHENOTYPING TO TREATMENT.
[3] T. Henzler,et al. A quantitative CT parameter for the assessment of pulmonary oedema in patients with acute respiratory distress syndrome , 2020, PloS one.
[4] T. Dolinay,et al. Post-COVID recovery: characteristics of chronically critically ill patients admitted to a long-term acute care hospital , 2020, F1000Research.
[5] E. Thwaite,et al. Respiratory follow-up of patients with COVID-19 pneumonia , 2020, Thorax.
[6] Maansi Parekh,et al. Review of the Chest CT Differential Diagnosis of Ground-Glass Opacities in the COVID Era , 2020, Radiology.
[7] E. Bateman,et al. Transition from Restrictive to Obstructive Lung Function Impairment During Treatment and Follow-Up of Active Tuberculosis , 2020, International journal of chronic obstructive pulmonary disease.
[8] Laura C Myers,et al. Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California. , 2020, JAMA.
[9] Ting Yu,et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.
[10] S. Walsh,et al. Visual and Automated CT Measurements of Lung Volume Loss in Idiopathic Pulmonary Fibrosis. , 2019, AJR. American journal of roentgenology.
[11] M. Roth,et al. Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II , 2018, Annals of the American Thoracic Society.
[12] Michael R Kramer,et al. Mortality Trends of Acute Respiratory Distress Syndrome in the United States from 1999 to 2013. , 2016, Annals of the American Thoracic Society.
[13] Anders Larsson,et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.
[14] J. Goldin,et al. Comparison of the quantitative CT imaging biomarkers of idiopathic pulmonary fibrosis at baseline and early change with an interval of 7 months. , 2015, Academic radiology.
[15] Arthur S Slutsky,et al. Mechanical Ventilation–associated Lung Fibrosis in Acute Respiratory Distress Syndrome: A Significant Contributor to Poor Outcome , 2014, Anesthesiology.
[16] G. Downey,et al. The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance , 2013, European Respiratory Journal.
[17] R. Hyzy,et al. Chest CT Features are Associated With Poorer Quality of Life in Acute Lung Injury Survivors* , 2013, Critical care medicine.
[18] J. Rello,et al. Quality of life, pulmonary function, and tomographic scan abnormalities after ARDS. , 2011, Chest.
[19] M S Brown,et al. A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients. , 2010, Clinical and experimental rheumatology.
[20] G. Nakos,et al. Prone position augments recruitment and prevents alveolar overinflation in acute lung injury. , 2006, American journal of respiratory and critical care medicine.
[21] Diane P. Martin,et al. Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.
[22] Arthur S Slutsky,et al. One-year outcomes in survivors of the acute respiratory distress syndrome. , 2003, The New England journal of medicine.
[23] G. Laurent,et al. The acute respiratory distress syndrome: fibrosis in the fast lane , 1998, Thorax.